Connection

Zdzislaw Szulc to Phosphotransferases (Alcohol Group Acceptor)

This is a "connection" page, showing publications Zdzislaw Szulc has written about Phosphotransferases (Alcohol Group Acceptor).
  1. Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis. Prostaglandins Other Lipid Mediat. 2017 05; 130:47-56.
    View in: PubMed
    Score: 0.121
  2. Substrate specificity of human ceramide kinase. J Lipid Res. 2005 Dec; 46(12):2706-16.
    View in: PubMed
    Score: 0.054
  3. Cationic ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors. J Photochem Photobiol B. 2013 Sep 05; 126:72-7.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.